Source link : https://www.newshealth.biz/health-news/no-benefit-seen-in-holding-ra-spa-meds-for-covid-19-vaccine/
WASHINGTON — There is no benefit to interrupting treatment with many of the available targeted synthetic or biologic disease-modifying antirheumatic drugs for rheumatoid arthritis (RA) or spondyloarthritis (SpA) at the time of a repeat COVID-19 vaccine dose, new research found. In the multicenter, randomized controlled COVID Vaccine Response (COVER) trial of 577 patients with RA […]
Author : News Health
Publish date : 2024-11-19 10:52:04
Copyright for syndicated content belongs to the linked Source.
inHealth